Stay updated with breaking news from Continuous Manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulators and a handful of Big Pharmas have been pushing continuous drug manufacturing for years, but despite plenty of buzz, the industry has been slow on the uptake. With COVID-19 spotlighting the global pharmaceutical supply chain, the approach may finally get its moment to shine.
Credits: Courtesy of Multiply Labs Caption: The engineering team of Multiply Labs. Credits: Courtesy of Multiply Labs Previous image Next image Over the last two years, Multiply Labs has helped pharmaceutical companies produce biologic drugs with its robotic manufacturing platform. The robots can work around the clock, precisely formulating small batches of drugs to help companies run clinical trials more quickly. Now Multiply Labs, which was founded by Fred Parietti PhD ’16 and former visi...
A new scientific journey in a foreign country No matter how long you have stayed in your hometown or somewhere else in the world, I believe that every scientific journey is worth sharing, so feel free to spread your own unique experiences with me and others! Here, I would like to share my experience of studying abroad, which meant leaving my home country Vietnam and travel to the United Kingdom. I will divide my experience into three key themes including: (1) Studying-doing research; (2) Working-volunteering, and (3) Traveling-joining extra activities. 1. Studying – Doing research I recog...
Navigating The Adoption Of Continuous Pharma Manufacturing Amid Unprecedented Global Challenges Source: Thermo Fisher Scientific By Ajaz Hussain, Independent Consultant, and Jessica Settimi, Senior Director, Continuous Manufacturing, Thermo Fisher Scientific In addition to the devastating impact the COVID-19 global pandemic has had on public health, the economy, and the overall quality of our day-to-day lives, it has also exposed significant risks in today’s pharmaceutical supply chain. Improvements in speed to market and quality assurance, among other factors, need to be made to ensure not...
Navigating The Adoption Of Continuous Pharma Manufacturing Amid Unprecedented Global Challenges Source: Thermo Fisher Scientific By Ajaz Hussain, Independent Consultant, and Jessica Settimi, Senior Director, Continuous Manufacturing, Thermo Fisher Scientific In addition to the devastating impact the COVID-19 global pandemic has had on public health, the economy, and the overall quality of our day-to-day lives, it has also exposed significant risks in today’s pharmaceutical supply chain. Improvements in speed to market and quality assurance, among other factors, need to be made to ensure not...